Zealand Pharma strikes deal with Generate worth up to $1.2 billion

Danish drugmaker Zealand Pharma OMXCOP:ZEAL and Generate Biomedicines NASDAQ:GENB have struck a deal worth up to nearly $1.2 billion to develop obesity treatments using artificial intelligence, Bloomberg News reported on Tuesday.The agreement includes $30 million upfront and $35 million in early mi…